Risk assessment for the carotenoids lutein and lycopene

Regulatory Toxicology and Pharmacology

Volumn 45, Issue 3, 2006, Pages 289-298

  Shao, Andrew ^a   Hathcock, John N ^a  

^a International and Scientific Affairs   (United States)

Author keywords

Carotenoids; Lutein; Lycopene; Observed Safe Level (OSL); Upper Level of Intake (UL)

Indexed keywords

CAROTENOID; LYCOPENE; XANTHOPHYLL;

ABSENCE OF SIDE EFFECTS; ARTICLE; CAROTENODERMIA; CLINICAL TRIAL; DATA ANALYSIS; DIET SUPPLEMENTATION; DRUG SAFETY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN DISCOLORATION;

ANIMALS; CAROTENOIDS; DIET; DRUG ADMINISTRATION SCHEDULE; HUMANS; LUTEIN; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; SAFETY;

ANIMALIA;

EID: 33746001403     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2006.05.007     Document Type: Article

References (94)

1. Center for Food Safety and Applied Nutrition. Food and Drug Administration, 2006. Qualified Health Claims. Rockville, MD. http://www.cfsan.fda.gov/~dms/lab-qhc.html.
2. Eye Disease Case-Control Study Group, 1993. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 111, 104-109.
3. Food and Nutrition Board. Institute of Medicine, 1997. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy Press, Washington, DC.
4. Food and Nutrition Board. Institute of Medicine, 1998a. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. National Academy Press, Washington, DC.
5. Food and Nutrition Board. Institute of Medicine, 1998b. Dietary Reference Intakes: A Risk Assessment Model for Establishing Upper Intake Levels for Nutrients. National Academy Press, Washington, DC.
6. Food and Nutrition Board. Institute of Medicine, 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. National Academy Press, Washington, D.C.
7. Food and Nutrition Board. Institute of Medicine, 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium and Zinc. National Academy Press, Washington, DC.
8. Food Standards Agency, 2003. Expert Group on Vitamins and Minerals: Safe Upper Levels for Vitamins and Minerals. United Kingdom.
9. Food and Agriculture Organization/World Health Organization, 2006. A Model for Establishing Upper Levels of Intake for Nutrients and Related Substances. FAO/WHO Technical Workshop on Risk Assessment. Geneva, Switzerland.
10. National Research Council, 1983. Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC.
11. NHANES III, 1999. Use of dietary supplements in the United States, 1988-1994. In: Vital and Health Statistics from the Centers for Disease Control and Prevention. National Center for Health Statistics.
12. Scientific Committee on Food, 2001. Guidelines of the Scientific Committee on Food for the Development of Tolerable Upper Intake Levels for Vitamins and Minerals. European Commission, Brussels, Belgium.
13. Albanes D., Heinonen O.P., Huttunen J.K., Taylor P.R., Virtamo J., Edwards B.K., Haapakoski J., Rautalahti M., Hartman A.M., Palmgren J., et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 62 (1995) 1427S-1430S
14. Aleman T.S., Duncan J.L., Bieber M.L., de Castro E., Marks D.A., Gardner L.M., Steinberg J.D., Cideciyan A.V., Maguire M.G., and Jacobson S.G. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1873-1881
15. Alves-Rodrigues A., and Shao A. The science behind lutein. Toxicol. Lett. 150 (2004) 57-83
16. Ansari M.S., and Gupta N.P. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int. 92 (2003) 375-378 discussion 378
17. Arab L., and Steck S. Lycopene and cardiovascular disease. Am. J. Clin. Nutr. 71 (2000) 1691S-1695S discussion 1696S-1697S
18. Astley S.B., Hughes D.A., Wright A.J., Elliott R.M., and Southon S. DNA damage and susceptibility to oxidative damage in lymphocytes: effects of carotenoids in vitro and in vivo. Br. J. Nutr. 91 (2004) 53-61
19. Bahrami H., Melia M., and Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol. 6 (2006) 23
20. Bendich A. The safety of beta-carotene. Nutr. Cancer. 11 (1988) 207-214
21. Berendschot T.T., Goldbohm R.A., Klopping W.A., van de Kraats J., van Norel J., and van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest. Ophthalmol Vis Sci. 41 (2000) 3322-3326
22. Bone R.A., Landrum J.T., Guerra L.H., and Ruiz C.A. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J. Nutr. 133 (2003) 992-998
23. Borel P. Factors affecting intestinal absorption of highly lipophilic food microconstituents (fat-soluble vitamins, carotenoids and phytosterols). Clin. Chem. Lab. Med. 41 (2003) 979-994
24. Briviba K., Kulling S.E., Moseneder J., Watzl B., Rechkemmer G., and Bub A. Effects of supplementing a low-carotenoid diet with a tomato extract for 2 weeks on endogenous levels of DNA single strand breaks and immune functions in healthy non-smokers and smokers. Carcinogenesis 25 (2004) 2373-2378
25. Brown L., Rimm E.B., Seddon J.M., Giovannucci E.L., Chasan-Taber L., Spiegelman D., Willett W.C., and Hankinson S.E. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am. J. Clin. Nutr. 70 (1999) 517-524
26. Cardinault N., Gorrand J.M., Tyssandier V., Grolier P., Rock E., and Borel P. Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects. Exp. Gerontol. 38 (2003) 573-582
27. Castenmiller J.J., and West C.E. Bioavailability and bioconversion of carotenoids. Annu. Rev. Nutr. 18 (1998) 19-38
28. Chan J.M., Gann P.H., and Giovannucci E.L. Role of diet in prostate cancer development and progression. J. Clin. Oncol. 23 (2005) 8152-8160
29. Chasan-Taber L., Willett W.C., Seddon J.M., Stampfer M.J., Rosner B., Colditz G.A., Speizer F.E., and Hankinson S.E. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am. J. Clin. Nutr. 70 (1999) 509-516
30. Chen L., Stacewicz-Sapuntzakis M., Duncan C., Sharifi R., Ghosh L., van Breemen R., Ashton D., and Bowen P.E. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 93 (2001) 1872-1879
31. Cohn W., Thurmann P., Tenter U., Aebischer C., Schierle J., and Schalch W. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur. J. Nutr. 43 (2004) 304-312
32. Corridan B.M., O'Donoghue M., Hughes D.A., and Morrissey P.A. Low-dose supplementation with lycopene or beta-carotene does not enhance cell-mediated immunity in healthy free-living elderly humans. Eur. J. Clin. Nutr. 55 (2001) 627-635
33. Cotton P.A., Subar A.F., Friday J.E., and Cook A. Dietary sources of nutrients among US adults, 1994 to 1996. J. Am. Diet Assoc. 104 (2004) 921-930
34. Dagnelie G., Zorge I.S., and McDonald T.M. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 71 (2000) 147-164
35. Duncan J.L., Aleman T.S., Gardner L.M., De Castro E., Marks D.A., Emmons J.M., Bieber M.L., Steinberg J.D., Bennett J., Stone E.M., MacDonald I.M., Cideciyan A.V., Maguire M.G., and Jacobson S.G. Macular pigment and lutein supplementation in choroideremia. Exp. Eye Res. 74 (2002) 371-381
36. Falsini B., Piccardi M., Iarossi G., Fadda A., Merendino E., and Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology 110 (2003) 51-60 discussion 61
37. Fraser P.D., and Bramley P.M. The biosynthesis and nutritional uses of carotenoids. Prog. Lipid Res. 43 (2004) 228-265
38. Gale C.R., Hall N.F., Phillips D.I., and Martyn C.N. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 108 (2001) 1992-1998
39. Gartner C., Stahl W., and Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am. J. Clin. Nutr. 66 (1997) 116-122
40. Giovannucci E. Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. J. Nutr. 135 (2005) 2030S-2031S
41. Goralczyk R., Barker F.M., Buser S., Liechti H., and Bausch J. Dose dependency of canthaxanthin crystals in monkey retina and spatial distribution of its metabolites. Invest. Ophthalmol Vis. Sci. 41 (2000) 1513-1522
42. Goralczyk R., Buser S., Bausch J., Bee W., Zuhlke U., and Barker F.M. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin. Invest. Ophthalmol. Vis. Sci. 38 (1997) 741-752
43. Granado F., Olmedilla B., Gil-Martinez E., and Blanco I. Lutein ester in serum after lutein supplementation in human subjects. Br. J. Nutr. 80 (1998) 445-449
44. Hathcock J. Vitamin and Mineral Safety (2004), Council for Responsible Nutrition, Washington, DC
45. Hininger I.A., Meyer-Wenger A., Moser U., Wright A., Southon S., Thurnham D., Chopra M., Van Den Berg H., Olmedilla B., Favier A.E., and Roussel A.M. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J. Am. Coll. Nutr. 20 (2001) 232-238
46. Holden J.M., Eldridge A.L., Beecher G.R., Buzzard I.M., Bhagwat S., Davis C.S., Douglass L.W., Gebhardt S., Haytowitz D., and Schakel S. Carotenoid content of U.S. foods: an update of the database. J. Food Comp. Anal. 12 (1999) 169-196
47. Hoppe P.P., Kramer K., van den Berg H., Steenge G., and van Vliet T. Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur. J. Nutr. 42 (2003) 272-278
48. Horvitz M.A., Simon P.W., and Tanumihardjo S.A. Lycopene and beta-carotene are bioavailable from lycopene 'red' carrots in humans. Eur. J. Clin. Nutr. 58 (2004) 803-811
49. Hughes D.A., Wright A.J., Finglas P.M., Polley A.C., Bailey A.L., Astley S.B., and Southon S. Effects of lycopene and lutein supplementation on the expression of functionally associated surface molecules on blood monocytes from healthy male nonsmokers. J. Infect. Dis. 182 Suppl 1 (2000) S11-S15
50. Jenkins M.Y., Mitchell G.V., and Grundel E. Natural tocopherols in a dietary supplement of lutein affect tissue distribution of tocopherols in young rats. Nutr. Cancer 37 (2000) 207-214
51. Johnson E.J. The role of carotenoids in human health. Nutr. Clin. Care. 5 (2002) 56-65
52. Johnson E.J., Hammond B.R., Yeum K.J., Qin J., Wang X.D., Castaneda C., Snodderly D.M., and Russell R.M. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am. J. Clin. Nutr. 71 (2000) 1555-1562
53. Khachik F., Carvalho L., Bernstein P.S., Muir G.J., Zhao D.Y., and Katz N.B. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp. Biol. Med. (Maywood) 227 (2002) 845-851
54. Khachik F., Spangler C.J., Smith Jr. J.C., Canfield L.M., Steck A., and Pfander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem. 69 (1997) 1873-1881
55. Koh H.H., Murray I.J., Nolan D., Carden D., Feather J., and Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp. Eye Res. 79 (2004) 21-27
56. Kruger C.L., Murphy M., DeFreitas Z., Pfannkuch F., and Heimbach J. An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product. Food Chem. Toxicol. 40 (2002) 1535-1549
57. Kucuk O., Sarkar F.H., Djuric Z., Sakr W., Pollak M.N., Khachik F., Banerjee M., Bertram J.S., and Wood Jr. D.P. Effects of lycopene supplementation in patients with localized prostate cancer. Exp. Biol. Med. (Maywood) 227 (2002) 881-885
58. Kucuk O., Sarkar F.H., Sakr W., Djuric Z., Pollak M.N., Khachik F., Li Y.W., Banerjee M., Grignon D., Bertram J.S., Crissman J.D., Pontes E.J., and Wood Jr. D.P. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 861-868
59. La Placa M., Pazzaglia M., and Tosti A. Lycopenaemia. J. Eur. Acad. Dermatol. Venereol. 14 (2000) 311-312
60. Landrum J.T., and Bone R.A. Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys. 385 (2001) 28-40
61. Le Marchand L., Hankin J.H., Bach F., Kolonel L.N., Wilkens L.R., Stacewicz-Sapuntzakis M., Bowen P.E., Beecher G.R., Laudon F., Baque P., et al. An ecological study of diet and lung cancer in the South Pacific. Int. J. Cancer 63 (1995) 18-23
62. Liu C., Lian F., Smith D.E., Russell R.M., and Wang X.D. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res. 63 (2003) 3138-3144
63. Liu C., Russell R.M., and Wang X.D. Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J. Nutr. 136 (2006) 106-111
64. Lyle B.J., Mares-Perlman J.A., Klein B.E., Klein R., and Greger J.L. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 149 (1999) 801-809
65. Mares-Perlman J.A., Fisher A.I., Klein R., Palta M., Block G., Millen A.E., and Wright J.D. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am. J. Epidemiol. 153 (2001) 424-432
66. Maruyama C., Imamura K., Oshima S., Suzukawa M., Egami S., Tonomoto M., Baba N., Harada M., Ayaori M., Inakuma T., and Ishikawa T. Effects of tomato juice consumption on plasma and lipoprotein carotenoid concentrations and the susceptibility of low density lipoprotein to oxidative modification. J. Nutr. Sci. Vitaminol. (Tokyo) 47 (2001) 213-221
67. Matulka R.A., Hood A.M., and Griffiths J.C. Safety evaluation of a natural tomato oleoresin extract derived from food-processing tomatoes. Regul. Toxicol. Pharmacol. 39 (2004) 390-402
68. McClain R.M., and Bausch J. Summary of safety studies conducted with synthetic lycopene. Regul. Toxicol. Pharmacol. 37 (2003) 274-285
69. Neuman I., Nahum H., and Ben-Amotz A. Reduction of exercise-induced asthma oxidative stress by lycopene, a natural antioxidant. Allergy 55 (2000) 1184-1189
70. Olmedilla B., Granado F., Blanco I., and Vaquero M. Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition 19 (2003) 21-24
71. Olmedilla B., Granado F., Southon S., Wright A.J., Blanco I., Gil-Martinez E., van den Berg H., Thurnham D., Corridan B., Chopra M., and Hininger I. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Clin. Sci. (Lond). 102 (2002) 447-456
72. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens Jr. F.L., Valanis B., Williams Jr. J.H., Barnhart S., Cherniack M.G., Brodkin C.A., and Hammar S. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J. Natl. Cancer Inst. 88 (1996) 1550-1559
73. Paetau I., Khachik F., Brown E.D., Beecher G.R., Kramer T.R., Chittams J., and Clevidence B.A. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am. J. Clin. Nutr. 68 (1998) 1187-1195
74. Paetau I., Rao D., Wiley E.R., Brown E.D., and Clevidence B.A. Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am. J. Clin. Nutr. 70 (1999) 490-494
75. Rao A.V., and Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr. Cancer 31 (1998) 199-203
76. Reigh P. Lycopenemia: a variant of carotenemia. New Engl. J. Med. 80 (1960) 353-361
77. Richelle M., Bortlik K., Liardet S., Hager C., Lambelet P., Baur M., Applegate L.A., and Offord E.A. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J. Nutr. 132 (2002) 404-408
78. Richer S. ARMD-pilot (case series) environmental intervention data. J. Am. Optom. Assoc. 70 (1999) 24-36
79. Richer S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., Pei K., Tsipursky M., and Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75 (2004) 216-230
80. Roodenburg A.J., Leenen R., van het Hof K.H., Weststrate J.A., and Tijburg L.B. Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans. Am. J. Clin. Nutr. 71 (2000) 1187-1193
81. Russell R.M. The vitamin A spectrum: from deficiency to toxicity. Am. J. Clin. Nutr. 71 (2000) 878-884
82. Russell R.M. The enigma of beta-carotene in carcinogenesis: what can be learned from animal studies. J. Nutr. 134 (2004) 262S-268S
83. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. J. Am. Med. Assoc. 272 (1994) 1413-1420
84. Tang G., Ferreira A.L., Grusak M.A., Qin J., Dolnikowski G.G., Russell R.M., and Krinsky N.I. Bioavailability of synthetic and biosynthetic deuterated lycopene in humans. J. Nutr. Biochem. 16 (2005) 229-235
85. Thurmann P.A., Schalch W., Aebischer J.C., Tenter U., and Cohn W. Plasma kinetics of lutein, zeaxanthin, and 3-dehydro-lutein after multiple oral doses of a lutein supplement. Am. J. Clin. Nutr. 82 (2005) 88-97
86. van Breemen R.B. How do intermediate endpoint markers respond to lycopene in men with prostate cancer or benign prostate hyperplasia?. J. Nutr. 135 (2005) 2062S-2064S
87. Wang X.D. Can smoke-exposed ferrets be utilized to unravel the mechanisms of action of lycopene?. J. Nutr. 135 (2005) 2053S-2056S
88. Wang X.D., Liu C., Bronson R.T., Smith D.E., Krinsky N.I., and Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91 (1999) 60-66
89. Watzl B., Bub A., Blockhaus M., Herbert B.M., Luhrmann P.M., Neuhauser-Berthold M., and Rechkemmer G. Prolonged tomato juice consumption has no effect on cell-mediated immunity of well-nourished elderly men and women. J. Nutr. 130 (2000) 1719-1723
90. Watzl B., Bub A., Briviba K., and Rechkemmer G. Supplementation of a low-carotenoid diet with tomato or carrot juice modulates immune functions in healthy men. Ann. Nutr. Metab. 47 (2003) 255-261
91. West C.E., and Castenmiller J.J. Quantification of the "SLAMENGHI" factors for carotenoid bioavailability and bioconversion. Int. J. Vitam. Nutr. Res. 68 (1998) 371-377
92. Willcox J.K., Catignani G.L., and Lazarus S. Tomatoes and cardiovascular health. Crit. Rev. Food Sci. Nutr. 43 (2003) 1-18
93. Yeum K.J., Taylor A., Tang G., and Russell R.M. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest. Ophthalmol. Vis. Sci. 36 (1995) 2756-2761
94. Zhao X., Aldini G., Johnson E.J., Rasmussen H., Kraemer K., Woolf H., Musaeus N., Krinsky N.I., Russell R.M., and Yeum K.J. Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women. Am. J. Clin. Nutr. 83 (2006) 163-169